{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:49:17Z","timestamp":1786650557616,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Niger Med J"],"published-print":{"date-parts":[[2013]]},"DOI":"10.4103\/0300-1652.122328","type":"journal-article","created":{"date-parts":[[2013,11,28]],"date-time":"2013-11-28T06:06:33Z","timestamp":1385618793000},"page":"289","source":"Crossref","is-referenced-by-count":6,"title":["Recombinant activated factor VII in post partum haemorrhage"],"prefix":"10.4103","volume":"54","author":[{"given":"Navneet","family":"Magon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KM","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishan","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjiv","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GurdarshanSingh","family":"Joneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0300-1652.122328-1","first-page":"77","volume-title":"Who\u2032s got the power.Transforming health systems for women and children?","author":"Lynn","year":"2005","journal-title":"UN Millenium Project Task Force Child Health Maternal Health"},{"key":"key-10.4103\/0300-1652.122328-2","first-page":"69","volume-title":"Factors associated with postpartum hemorrhage with vaginal birth","author":"Combs","year":"1991","journal-title":"Obstet Gynecol"},{"key":"key-10.4103\/0300-1652.122328-3","first-page":"1","volume-title":"The tolerance of freshly delivered women to excessive loss of blood","author":"Williams","year":"1919","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.4103\/0300-1652.122328-4","first-page":"119","volume-title":"Discrepancy between laboratory determination and visual estimation of blood loss during normal delivery","author":"Duthie","year":"1991","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key-10.4103\/0300-1652.122328-5","unstructured":"World Health Organization. The Prevention and Management of Postpartum Haemorrhage. Report of a Technical Working Group, Geneva, 3-6 July, 1989. Unpublished document. WHO\/ MCH\/90.7. Geneva: World Health Organization; 1990."},{"key":"key-10.4103\/0300-1652.122328-6","unstructured":"Gulmezoglu AM. Postpartum haemorrhage (1997-2002). Monitoring and Evaluation Department of Reproductive Health and Research, 25-26 May 2004. Geneva: WHO; 2004."},{"key":"key-10.4103\/0300-1652.122328-7","first-page":"49","volume-title":"Using the kanga to measure postpartum blood loss","author":"Prata","year":"2005","journal-title":"Int J Gynaecol Obstet"},{"key":"key-10.4103\/0300-1652.122328-8","first-page":"595","volume-title":"Major postpartum haemorrhage","author":"Mousa","year":"2001","journal-title":"Curr Opin Obstet Gynecol"},{"key":"key-10.4103\/0300-1652.122328-9","first-page":"1066","volume-title":"WHO analysis of maternal death: A systematic review","author":"Khan","year":"2006","journal-title":"Lancet"},{"key":"key-10.4103\/0300-1652.122328-10","first-page":"519","volume-title":"Massive postpartum haemorrhage as a cause of maternal morbidity in a tertiary hospital","author":"Hazra","year":"2004","journal-title":"J Obstet Gynaecol"},{"key":"key-10.4103\/0300-1652.122328-11","first-page":"341","volume-title":"Emergency postpartum hysterectomy in obstetric practice","author":"Yamamoto","year":"2000","journal-title":"J Obstet Gynaecol Res"},{"key":"key-10.4103\/0300-1652.122328-12","first-page":"790","volume-title":"A randomized, double-blind comparison of two doses levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors.rFVIIa Study Group","author":"Luster","year":"1998","journal-title":"Haemophilia"},{"key":"key-10.4103\/0300-1652.122328-13","first-page":"174","volume-title":"Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII","author":"Moscardo","year":"2001","journal-title":"Br J Haematol"},{"key":"key-10.4103\/0300-1652.122328-14","first-page":"1174","volume-title":"Successful treatment of life-threatening postpartum haemorrhage with recombinant activated factor VII","author":"Bouwmeester","year":"2003","journal-title":"Obstet Gynecol"},{"key":"key-10.4103\/0300-1652.122328-15","first-page":"592","volume-title":"Recombinant factor VIIa for life-threatening post-partum haemorrhage","author":"Ahonen","year":"2005","journal-title":"Br J Anaesth"},{"key":"key-10.4103\/0300-1652.122328-16","first-page":"e41","volume-title":"Italian rFVIIa-PPH Study Group.Use of recombinant activated factor VII in severe post-partum haemorrhage: Data from the Italian Registry: A multicentric observational retrospective study","author":"Barillari","year":"2009","journal-title":"Thromb Res"},{"key":"key-10.4103\/0300-1652.122328-17","first-page":"157","volume-title":"Recombinant Factor VIIa in Post-partum hemorrhage: A new weapon in Obstetrician\u2032s armamentarium","author":"Magon","year":"2012","journal-title":"N Am J Med Sci"},{"key":"key-10.4103\/0300-1652.122328-18","unstructured":"Magon N, Babu KM. Recombinant Factor VIIa in PPH in a diabetic primigravida. [Unpublished data]."},{"key":"key-10.4103\/0300-1652.122328-19","first-page":"43","volume-title":"Recombinant factor VIIa (NovoSeven) as a haemostatic agent","author":"Hedner","year":"2001","journal-title":"Semin Hematol"},{"key":"key-10.4103\/0300-1652.122328-20","first-page":"1564","volume-title":"How we treat: Management of life-threatening primary postpartum hemorrhage with a standardized massive transfusion protocol","author":"Burtelow","year":"2007","journal-title":"Transfusion"},{"key":"key-10.4103\/0300-1652.122328-21","first-page":"S61","volume-title":"Activated Factor VII activates Factor IX and X on surface of activated platelets: Thoughts on the mechanism of action of high-dose activated Factor VII","author":"Hoffman","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"key-10.4103\/0300-1652.122328-22","first-page":"1330","volume-title":"Inhibition of thrombin generation by the zymogen factor VII: Implications for the treatment of hemophilia A by factor VIIa","author":"van\u2032t","year":"2000","journal-title":"Blood"},{"key":"key-10.4103\/0300-1652.122328-23","first-page":"1138","volume-title":"Mechanism of action of recombinant factor VIIa","author":"Lisman","year":"2003","journal-title":"J Thromb Haemost"},{"key":"key-10.4103\/0300-1652.122328-24","first-page":"749","volume-title":"Effect of recombinant factor VIIa on endotoxin-induced disseminated intravascular coagulation in rabbits","author":"Bregeng\u00e5rd","year":"1993","journal-title":"Thromb Haemost"},{"key":"key-10.4103\/0300-1652.122328-25","first-page":"640","volume-title":"Israeli Multidisciplinary rFVIIa Task Force.Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: A report by the Israeli Multidisciplinary rFVIIa Task Force","author":"Martinowitz","year":"2005","journal-title":"J Thromb Haemost"},{"key":"key-10.4103\/0300-1652.122328-26","first-page":"101","volume-title":"Safety profile of recombinant factor VIIa","author":"Roberts","year":"2004","journal-title":"Semin Hematol"},{"key":"key-10.4103\/0300-1652.122328-27","first-page":"1700","volume-title":"Comparative thrombotic event incidences after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity","author":"Aledort","year":"2004","journal-title":"J Thromb Haemost"},{"key":"key-10.4103\/0300-1652.122328-28","first-page":"245","volume-title":"Recombinant factor VIIa does not induce hypercoagulability in vitro","author":"Gallistl","year":"1999","journal-title":"Thromb Haemost"},{"key":"key-10.4103\/0300-1652.122328-29","first-page":"40","volume-title":"Use of recombinant activated factor VII in massive obstetric hemorrhage","author":"Haynes","year":"2007","journal-title":"Int J Obstet Anesth"},{"key":"key-10.4103\/0300-1652.122328-30","first-page":"12","volume-title":"Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage","author":"Welsh","year":"2008","journal-title":"Aust N Z J Obstet Gynaecol"}],"container-title":["Nigerian Medical Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:20:16Z","timestamp":1786648816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0300-1652.122328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"alternative-id":["122328"],"URL":"https:\/\/doi.org\/10.4103\/0300-1652.122328","relation":{},"ISSN":["0300-1652"],"issn-type":[{"value":"0300-1652","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}